Clinical Trials Directory

Trials / Unknown

UnknownNCT05552209

Assessment of the Safety and Performance of Elbow Supports in the Context of Epicondylitis or a Return to Sport After Sprain

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Decathlon SE · Industry
Sex
All
Age
18 Years – 99 Years
Healthy volunteers

Summary

Decathlon has developed elbowMID500 and elbowSTRAP products which are medical devices that must be positioned around the elbow during sport practice, in order to limit symptoms related to epicondylitis or previous sprains (elbowMID500 only). The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon elbowMID500 and elbowSTRAP products to demonstrate safety and performance of these devices in a real-world setting. Outcome data collected from this study will provide the basis for Post-Market Surveillance (PMS) reporting, Clinical Study Report (CSR), Clinical Evaluation Report (CER) on Decathlon elbowMID500 and elbowSTRAP devices and support peer-reviewed publications on products performance and safety.

Conditions

Interventions

TypeNameDescription
DEVICEElbow MID 50015 patients will be included in this group and will used the medical device Elbow MID 500 during sport practice (at least 2 sport sessions per week), for 6 weeks.
OTHERControl group Elbow MID 50015 patients will be included in this control group and will performed their sport sessions as usual (without the medical device Elbow MID 500), for at least 2 sport sessions per week during 6 weeks.
DEVICEElbow STRAP15 patients will be included in this group and will used the medical device Elbow STRAP during sport practice (at least 2 sport sessions per week), for 6 weeks.
OTHERControl group Elbow STRAP15 patients will be included in this control group and will performed their sport sessions as usual (without the medical device Elbow STRAP), for at least 2 sport sessions per week during 6 weeks.

Timeline

Start date
2022-09-21
Primary completion
2023-10-01
Completion
2023-10-01
First posted
2022-09-23
Last updated
2023-01-17

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05552209. Inclusion in this directory is not an endorsement.